Private Portfolio Partners LLC Bristol Myers Squibb CO Transaction History

Private Portfolio Partners LLC

  • $529 Million
  • Q3 2024

A detailed history of Private Portfolio Partners LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Private Portfolio Partners LLC holds 22,532 shares of BMY stock, worth $1.33 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
22,532
Holding current value
$1.33 Million
% of portfolio
0.22%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
BUY
$39.66 - $51.75 $893,619 - $1.17 Million
22,532 New
22,532 $1.17 Million
Q1 2024

May 09, 2024
SELL
$47.98 - $54.4 $93,465 - $105,971
-1,948 Reduced 6.86%
26,441 $1.43 Million
Q4 2023

Feb 07, 2024
SELL
$48.48 - $57.85 $120,230 - $143,468
-2,480 Reduced 8.03%
28,389 $1.46 Million
Q3 2023

Nov 14, 2023
SELL
$57.89 - $64.73 $315,153 - $352,390
-5,444 Reduced 14.99%
30,869 $1.79 Million
Q2 2023

Aug 14, 2023
SELL
$63.71 - $70.74 $161,632 - $179,467
-2,537 Reduced 6.53%
36,313 $2.32 Million
Q1 2023

May 12, 2023
BUY
$65.71 - $74.53 $8,936 - $10,136
136 Added 0.35%
38,850 $2.69 Million
Q4 2022

Feb 01, 2023
BUY
$68.48 - $81.09 $5,341 - $6,325
78 Added 0.2%
38,714 $2.79 Million
Q3 2022

Mar 14, 2023
SELL
$0.13 - $76.84 $31 - $18,518
-241 Reduced 0.62%
38,636 $2.75 Million
Q3 2022

Nov 07, 2022
SELL
$0.13 - $76.84 $31 - $18,518
-241 Reduced 0.62%
38,636 $2.75 Million
Q2 2022

Mar 14, 2023
SELL
$72.62 - $79.98 $14,524 - $15,996
-200 Reduced 0.51%
38,877 $2.99 Million
Q2 2022

Aug 02, 2022
SELL
$72.62 - $79.98 $14,596 - $16,075
-201 Reduced 0.51%
38,877 $2.99 Million
Q1 2022

Mar 14, 2023
BUY
$61.48 - $73.72 $43,404 - $52,046
706 Added 1.84%
39,077 $2.85 Million
Q1 2022

May 12, 2022
BUY
$61.48 - $73.72 $43,466 - $52,120
707 Added 1.84%
39,078 $2.85 Million
Q4 2021

Mar 14, 2023
BUY
$53.63 - $62.52 $67,788 - $79,025
1,264 Added 3.41%
38,371 $2.39 Million
Q4 2021

Feb 14, 2022
BUY
$53.63 - $62.52 $67,734 - $78,962
1,263 Added 3.4%
38,371 $2.39 Million
Q3 2021

Mar 14, 2023
SELL
$59.17 - $69.31 $47,336 - $55,448
-800 Reduced 2.11%
37,107 $2.2 Million
Q3 2021

Nov 04, 2021
SELL
$59.17 - $69.31 $47,276 - $55,378
-799 Reduced 2.11%
37,108 $2.2 Million
Q2 2021

Mar 14, 2023
SELL
$61.91 - $67.42 $91,317 - $99,444
-1,475 Reduced 3.75%
37,907 $2.53 Million
Q2 2021

Aug 11, 2021
SELL
$61.91 - $67.42 $91,379 - $99,511
-1,476 Reduced 3.75%
37,907 $2.53 Million
Q1 2021

Mar 14, 2023
BUY
$59.34 - $66.74 $1,246 - $1,401
21 Added 0.05%
39,382 $2.49 Million
Q1 2021

May 17, 2021
BUY
$59.34 - $66.74 $1,246 - $1,401
21 Added 0.05%
39,383 $2.49 Million
Q4 2020

Mar 14, 2023
BUY
$57.74 - $65.43 $18,476 - $20,937
320 Added 0.82%
39,361 $2.44 Million
Q4 2020

Feb 16, 2021
BUY
$57.74 - $65.43 $18,534 - $21,003
321 Added 0.82%
39,362 $2.44 Million
Q3 2020

Mar 14, 2023
BUY
$57.43 - $63.64 $18,779 - $20,810
327 Added 0.84%
39,041 $2.35 Million
Q3 2020

Nov 16, 2020
BUY
$57.43 - $63.64 $52,031 - $57,657
906 Added 2.38%
39,041 $2.35 Million
Q2 2020

Aug 14, 2020
BUY
$54.82 - $64.09 $14,801 - $17,304
270 Added 0.71%
38,135 $2.24 Million
Q1 2020

May 14, 2020
BUY
$46.4 - $67.43 $50,112 - $72,824
1,080 Added 2.94%
37,865 $2.11 Million
Q4 2019

Feb 12, 2020
BUY
$49.21 - $64.19 $193,444 - $252,330
3,931 Added 11.97%
36,785 $2.36 Million
Q3 2019

Nov 13, 2019
SELL
$42.77 - $50.71 $9,708 - $11,511
-227 Reduced 0.69%
32,854 $1.67 Million
Q2 2019

Aug 14, 2019
BUY
$44.62 - $49.34 $292,216 - $323,127
6,549 Added 24.68%
33,081 $1.5 Million
Q1 2019

May 10, 2019
SELL
$45.12 - $53.8 $35,870 - $42,771
-795 Reduced 2.91%
26,532 $1.27 Million
Q4 2018

Feb 13, 2019
BUY
$48.76 - $63.23 $1.33 Million - $1.73 Million
27,327 New
27,327 $1.42 Million

Others Institutions Holding BMY

# of Institutions
2,602
Shares Held
1.46B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Private Portfolio Partners LLC Portfolio

Follow Private Portfolio Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Portfolio Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Portfolio Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email